News Center

Home page

Peak Report

News reports

Meet the challenge in the busy work

Release time:

2020-08-14

Meeting Challenges in Busy Work

Pharmaceutical Company 2017 Outstanding Scientific and Technological Workers Pharmaceutical Company Central Laboratory Han Ying

With the overall deepening of the national medical reform policy, 2017 is a challenging year for us as a member of the central laboratory, I also have a deep feeling that in the past year, the laboratory has been busy, tense and challenging.

Over the past year, the central laboratory has conscientiously performed its duties of GMP , made great efforts to improve its technical service capability, and completed daily testing of 683 batches of finished products (including 123 batches of Qiubin Factory and 560 batches of Jinxi Factory), 658 batches of raw materials and packaging materials, 1271 batches of process water; batches of intermediates, 538 batches of stability inspection products; Participated in more than ten process verification inspections, involving hundreds of samples; Completed the environmental monitoring work of 1102 batch of Jinxi Pharmaceutical Factory.

There are many new products in the past year. Inspection method confirmation and process verification should be done for new products. Faced with the situation of tight time, heavy tasks and insufficient personnel and instruments, all the laboratory staff did not flinch, faced up to the difficulties, overcame the difficulties, and successfully completed the inspection method verification and process verification of esomeprazole sodium, deoxypodophyllotoxin for injection and other products and related raw and auxiliary materials, totaling about 50 method confirmation.

My main job in the central laboratory is to assist the director to carry out departmental work and to be in charge of the laboratory raw material group. In order to play a good role in the post, do a good job in auxiliary work and manage the raw material group, I often go to various posts to understand the working conditions and be familiar with the testing instruments and the operation process of relevant posts.

raw material group involves many varieties, each batch of raw materials, chemical raw materials and packaging materials into the factory, need to be timely inspection, to ensure that qualified. In order to carry out the work of the raw material group smoothly, while assisting the department director, I have carried out reasonable division of labor and strict requirements on the personnel of the raw material group, and strengthened the maintenance and calibration of instruments.

I also attach great importance to the training of team members to improve their skills. In daily work, when there is a sudden failure of the inspection instrument, I will analyze the cause as soon as possible, solve it in time, ensure the normal inspection work, sum up experience, and learn and improve together with the staff.

Looking back over the past year, the reason why the central laboratory has been able to overcome various difficulties and successfully complete the company's inspection tasks is that we have continuously focused on management, process, detailed work, improved various rules and regulations, tapped the potential of employees, changed employees' working ideas , , strengthened theoretical study, attached importance to training, and improved the overall quality of the team. "Unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak forever" is our enterprise spirit. "Pragmatic innovation, steady behavior, standardized management and strong implementation" is the work style of our enterprise. Under the guidance of this spirit and style, I will continue to work hard and make persistent efforts to live up to the love of leaders and colleagues. (According to Han Ying's speech at the summary and commendation meeting of pharmaceutical companies)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页